Last reviewed · How we verify
NCT07412314
Proton Therapy for Recurrent Nasopharyngeal Carcinoma
NA trial testing Proton therapy in Recurrent Nasopharyngeal Carcinoma in 52 participants. Currently enrolling.
10 March 2028
Quick facts
| Lead sponsor | Guangzhou Concord Cancer Center |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 52 |
| Start date | 10 March 2025 |
| Primary completion | 10 March 2028 |
| Estimated completion | 10 March 2028 |
| Sites | 2 locations across China |
Drugs / interventions tested
- Proton therapy
- Proton radiation therapy
Conditions studied
- Recurrent Nasopharyngeal Carcinoma — all drugs for Recurrent Nasopharyngeal Carcinoma →
Sponsor
Guangzhou Concord Cancer Center
Who can join
18 and older, any sex, with Recurrent Nasopharyngeal Carcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The above studies show that most of the supportive evidence for the reduction of toxicity and improvement of efficacy of proton therapy for recurrent Nasopharyngeal carcinoma(NPC) comes from various observational and retrospective studies, lacking high-level evidence-based medical evidence. The conduct of this study will explore the safety and efficacy of intensity-modulated proton radiotherapy for recurrent NPC and provide more high-quality evidence-based medical evidence for proton therapy of recurrent cancer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07412314
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Proton therapy
Trials testing the same drug.
- NCT06462378 — Proton Therapy for Locally Advanced Cervical Cancer · Phase 2 · recruiting
- NCT05203120 — A National Phase II Study of Proton Therapy in Hepatocellular Carcinoma · NA · recruiting
- NCT05350475 — Protons Vs. Photons for High-risk Prostate Cancer · NA · recruiting
- NCT03018418 — Proton Therapy in Reducing Toxicity in Anal Cancer · Phase 2 · active not recruiting
Other recruiting trials for Recurrent Nasopharyngeal Carcinoma
Currently open trials in the same condition.
- NCT06029270 — Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Meta · Phase 2 · recruiting
- NCT06235203 — Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC · Phase 3 · recruiting
- NCT06228079 — Adjuvant vs Surgery Only in Early-stage Recurrent NPC · Phase 3 · recruiting
- NCT05904080 — Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, · Phase 2 · recruiting
- NCT05350891 — Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC · Phase 2 · recruiting
Other Guangzhou Concord Cancer Center trials
Trials by the same sponsor.
- NCT07412327 — A Single-Center, Prospective Phase II Clinical Study of Proton Beam Intensity-Modulated Stereotactic Radiotherapy for Ea · NA · not yet recruiting
- NCT05914142 — Study on the Safety and Effectiveness of Varian ProBeam Proton Therapy Equipment in the Treatment of Solid Tumors · NA · completed
- NCT06282887 — Effects of Music Therapy on Psychological States Among Cancer Patients Undergoing MRI Scans and a Relevant Mediator · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07412314 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guangzhou Concord Cancer Center
- Last refreshed: 9 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07412314.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing